SCHEMBL19153128

SCHEMBL19153128

Cc1cnc2nc[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 2/20 0.44
GLA P06280 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
XDH P47989 1/20 0.34
PAK1 Q13153 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
JAK3 P52333 2/20 0.32
CDK2 P24941 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4402266 0.83 KDM4E (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL26556504 0.74 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL29596196 0.74 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL29870750 0.74 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL28644122 0.74 KDM4E (0.40) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL18237721 0.74 KDM4E (0.40) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL21388594 0.74 KDM4E (0.40) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL11829105 0.73 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL19152997 0.72 KDM4E (0.38) ALDH1A1KDM4EHPGDGAACCNB2
SCHEMBL29870020 0.72 ALOX5AP (0.43) ALDH1A1KDM4EHPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022002118-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL USE THEREOF 四川海思科制药有限公司 2022-01-06 WO disclosed
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT ALDH1A1 2151/4885KDM4E 3060/4885HPGD 4543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.